Everything below concerns copper tripeptide-1. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2026-02-05. Where a claim depends on a specific study, the study is described rather than over-claimed.
Quality control for GHK-Cu relies on documentation and independent testing rather than a single accepted standard. A certificate of analysis may report peptide purity, copper content, residual solvents, water content, and microbial limits, but the underlying methods and acceptance criteria vary by supplier. Verification can include mass confirmation, amino acid analysis, and comparison with a reference standard when one is available. Open questions include how different copper-binding modes or peptide isomers affect measured activity and whether conventional purity assays capture those differences. Buyers of research-grade material typically need to request raw data rather than rely solely on a summary certificate.
Laboratory characterization of GHK-Cu typically combines separation, spectroscopic, and elemental techniques. Reverse-phase high-performance liquid chromatography is widely used to assess peptide purity, often with ultraviolet detection near the copper-related absorption band or with mass spectrometry for identity confirmation. Because the molecule contains copper, elemental methods such as inductively coupled plasma mass spectrometry or atomic absorption spectroscopy are used to quantify metal content and confirm stoichiometry. No single universal pharmacopeial monograph exists for GHK-Cu. Laboratories therefore validate their own methods, and reported purity values depend on the chosen assay and calibration standards.
The sequence now called GHK was first reported in the early 1970s after isolation from human plasma, where it was noted to influence liver cell behavior in laboratory preparations. Later work described a copper-binding form and its activity in fibroblast and wound-model experiments. Review articles frequently group the substance with other copper peptides. Concentrations in blood appear to fall with age in several small surveys, although the reason for this trend is not settled. Whether such a decline carries functional consequences remains an open question.
Published work on GHK-Cu concentrates largely on cell culture systems rather than whole organisms. Frequently used endpoints include collagen synthesis, expression of matrix metalloproteinases, and migration of fibroblasts. Some reports describe antioxidant behavior, while others stress delivery of copper into cells. These mechanisms are proposed rather than demonstrated, and the relative weight of each pathway is unclear. Human trials are few and generally small, so laboratory findings should not be read as confirmed clinical results.
GHK-Cu is a coordination complex formed between the tripeptide glycyl-L-histidyl-L-lysine and a copper(II) ion. The peptide backbone consists of glycine, histidine, and lysine joined in that order. Copper is held through the imidazole nitrogen of histidine and the alpha-amino group at the N-terminus, which together produce a square-planar arrangement around the metal center. The solid appears blue to violet, a color that originates from d-d electronic transitions within the copper coordination sphere. The complex is indexed under CAS number 89030-95-5.
| Property | Value | Notes |
|---|---|---|
| Primary identity method | Reverse-phase HPLC with mass spectrometry | Confirms peptide mass and retention behavior |
| Copper quantification | ICP-MS or atomic absorption spectroscopy | Measures metal content and stoichiometry |
| Spectroscopic feature | Visible absorption from copper(II) d-d transitions | Explains blue to blue-violet color |
| Recommended holding condition | Desiccated, protected from light, stored cold | Reduces hydrolysis, oxidation, and moisture uptake |
| Common purity check | HPLC area percent against a reference standard | Values depend on method and standard choice |
GHK-Cu is a coordination complex formed between the tripeptide glycyl-L-histidyl-L-lysine and a copper(II) ion. The peptide was isolated from human plasma in the early 1970s by Loren Pickart, who observed that a plasma fraction from young donors stimulated growth in cultured liver cells. The copper-bound form is abbreviated GHK-Cu, while the metal-free peptide is written simply as GHK. In the research literature the complex also appears as copper tripeptide-1 and as glycyl-histidyl-lysine copper complex.
Copper(II) binds the peptide through four nitrogen donors: the terminal amino group, the imidazole nitrogen of histidine, and two deprotonated amide nitrogens of the peptide backbone. This tetradentate arrangement gives a roughly square-planar geometry, the thermodynamically favoured form near neutral pH. Because the amide nitrogens must lose a proton before they can coordinate, complex formation is strongly pH-dependent, and the fully coordinated species dominates only above mildly acidic conditions. Electronic transitions within the copper d orbital set produce the characteristic blue to violet colour in aqueous solution.
Proposed mechanisms for copper peptide activity center on delivery of copper ions to cells and on peptide fragments acting as signaling molecules. Copper is a cofactor for enzymes involved in collagen cross-linking and antioxidant defense, and the peptide may improve its availability at target sites. Separately, the tripeptide and its breakdown products have been reported to influence gene expression in cultured fibroblasts. Much of this evidence comes from laboratory cell cultures and animal models rather than controlled human trials. The relative contribution of the copper ion and the peptide sequence is therefore not fully settled.
Stability depends on temperature, light exposure, moisture, and the presence of oxidizing or reducing agents. Solid material held dry and protected from light is generally more stable than aqueous solutions, which can undergo gradual degradation. Recommended storage in much of the literature is a freezer at around minus twenty degrees Celsius for long-term retention, with working aliquots kept cold and shielded from light. Repeated freeze-thaw cycles and alkaline pH are commonly noted as factors that accelerate loss of the intact complex, though exact degradation rates vary.
Analytical confirmation usually combines a separation method with a copper-specific measurement. Liquid chromatography or mass spectrometry establishes peptide identity and purity, while an elemental measurement quantifies the metal content. A frequent misconception is that any blue solution contains an intact copper peptide complex; color alone does not confirm structure, because free copper salts and degraded mixtures can also appear colored. Literature on efficacy is mixed, with in vitro findings often more dramatic than human evidence, and reviews note small sample sizes and short follow-up. Open questions include optimal concentration, skin penetration, and long-term effects.
GHK-Cu is a coordination complex formed between the tripeptide glycyl-L-histidyl-L-lysine and copper(II). The peptide sequence consists of glycine, histidine, and lysine, and its imidazole and amino groups provide binding sites for the metal ion. In the complex, copper is held through nitrogen donors from the histidine side chain, the N-terminal amine, and deprotonated amide nitrogens. The resulting compound is intensely blue and water-soluble. It occurs naturally in human plasma, saliva, and urine at low concentrations.
The peptide was first isolated from human albumin in 1973 by Loren Pickart, who later described its copper-binding behavior. Early work linked the complex to wound healing and tissue remodeling. Plasma levels of GHK decline with age, a pattern that stimulated interest in topical and supplemental applications. Researchers have reported that the tripeptide influences collagen synthesis, antioxidant defense, and inflammatory signaling in cell and animal models. Human clinical evidence remains limited and often relies on small studies.
Flughafen Pakse in Laos (IATA-Code) Pankreozym oder Cholecystokinin, ein gastrointestinales Peptid-Hormon Paul Kehl Zürich, Schweizer Modehaus-Kette, siehe PKZ (Schweiz) Personenkennzahl der DDR Petrócz, Kármán & Zurovec, Entwickler der ersten österreichisch-ungarischen Hubschrauber, siehe Stephan Petróczy von Petrócz Polizeikooperationszentrum in Österreich Pracownie Konserwacji Zabytków (PKZ), die Staatlichen Werkstätten für Denkmalpflege Polens Presskohlenheizung, Brikettheizung für Eisenbahnwagen (historisch) PKZ Keramika Poštorná, Unternehmen in Tschechien
Cathelicidine sind antimikrobielle Peptide, die hauptsächlich in Immunzellen von Wirbeltieren produziert werden und Teil der angeborenen Immunantwort sowie der Apoptose körpereigener Zellen sind. Es handelt sich um Transportproteine, deren Einbau einerseits in die Zellwand grampositiver Bakterien sowie andererseits in die Zellmembran zu einem Verlust von Ionen und kleinen Molekülen führt. Im Mensch ist das CAMP-Gen bekannt, das für zwei Cathelicidine codiert, die aus einem Vorläuferpeptid herausgeschnitten werden: FALL-39 und LL-37. Die Produktion von Cathelicidin wird insbesondere durch Stimulation des TLR-9, aber auch TLR-2 und TLR-4 und indirekt durch Vitamin D angeregt. Cathelicidin werden ebenfalls von den Zellen des Unterhautfettgewebes produziert und schützen so die Haut for Infektionen.
== Vorkommen == Cathelicidine sind als antimikrobielle Peptide in der Klasse der Säugetiere weit verbreitet. Besonders zahl- und variantenreich kommen sie in den Vertretern der Gruppe der Cetartiodactyla, zu denen insbesondere die Paarhufer gehören, vor. Der Mensch besitzt, wie die meisten anderen Säugetiere nur ein einziges Cathelicidin-Gen. Außerhalb der Klasse der Säugetiere konnten Cathelicidine nur vereinzelt, wie beispielsweise beim Haushuhn, nachgewiesen werden. Cathelicidin-ähnliche Peptide konnten auch bei der Regenbogenforelle und den Schleimaalen gefunden werden. Auf Grund dieser Verbreitung kann die evolutionsgeschichtliche Entstehung der Cathelicidine auf den Zeitraum von vor 500 bis 300 Millionen Jahren geschätzt werden.
=== Struktur === Die strukturell heterogene Familie der Cathelicidine beherbergt antimikrobielle Peptide mit einer Länge von 12 bis 80 Aminosäurebausteinen. Die größte Gruppe der Cathelicidine besteht aus 23 bis 37 Aminosäuren umfassenden Peptiden mit einer α-Helix-Struktur. Zu dieser Gruppe zählen die antimikrobiellen Peptide LL-37 und FALL-39 des Menschen. Eine weitere Gruppe stellen die aus 12 bis 18 Aminosäuren bestehende Peptide mit einer β-Schleifenstruktur dar, die über ein oder zwei Disulfidbrücken stabilisiert werden, dar. Dazu zählen beispielsweise die Protegrine des Schweins. Eine dritte Gruppe antimikrobieller Peptide der Cathelicidine bilden die aus 39 bis 80 Aminosäuren bestehenden überwiegend linearen Peptide mit Polyprolinmotiven. Zu ihnen gehören unter anderem Bac5 und Bac7 des Rinds und die Prophenine des Schweins. Eine von den übrigen Cathelicidinen verschiedene Struktur weist das Indolicidin des Rinds auf. Indolicidin ist ein aus 13 Aminosäuren bestehendes lineares, tryptophanreiches Peptid. Sie alle bestehen aus einer C-terminale kationische Domäne, welche nach Abspaltung aus einem Holoprotein aktiviert wird und für eine antimikrobielle Wirksamkeit verantwortlich ist.
Sources: de.wikipedia.org
Identification usually combines reverse-phase high-performance liquid chromatography with mass spectrometry. The copper content can be measured separately by inductively coupled plasma mass spectrometry or atomic absorption spectroscopy. The combination helps distinguish the intact complex from free peptide or free copper.
Light, oxygen, moisture, extreme pH, and elevated temperature can promote degradation or change copper coordination. Aqueous solutions are more vulnerable than dry solid because water enables hydrolysis and oxidation. Freeze-thaw cycling can also reduce sample quality.
A certificate of analysis summarizes tests performed by a supplier, but it does not guarantee that the material is suitable for every use. Methods, limits, and reporting practices differ between laboratories. Independent verification or raw data review is often needed for critical applications.
It is the copper complex of the tripeptide glycyl-L-histidyl-lysine. The metal ion is held by the histidine imidazole group and the peptide N-terminus. Most research on it concerns skin and wound models.